New laser method for corneal transplant in Fuchs' dystrophy
Part of Eyes & vision, Genetic & congenital clinical trials.
This trial tests a new way to perform a corneal transplant (DSAEK) using a laser to prepare the donor tissue. It may help people with Fuchs' dystrophy or certain types of corneal swelling, but not those with glaucoma, scarring, or other eye diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Fuchs' endothelial dystrophy or bullous keratopathy (swelling of the clear front of the eye) after eye surgery, iritis, or viral infection.
- Your eye swelling is not caused by glaucoma or an eye injury.
- You do not have scars or cloudiness in the cornea (the clear window at the front of your eye).
- You do not have a thinning or cone-shaped cornea (like keratoconus), or other dystrophies affecting the front layers of the cornea.
- You do not have low eye pressure, retinal disease, or optic nerve damage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific type of cornea transplant (called endothelial lamellar transplant) for people with Fuchs disease or other causes of corneal swelling that affect vision. It aims to see whether this surgical approach improves outcomes and quality of life after surgery.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
This trial tests a new treatment, EO2002, for people with corneal swelling that causes vision loss. It aims to offer an alternative to corneal transplant for those with conditions like Fuchs dystrophy or swelling after cataract surgery.
This study looks at how well people do after a specific type of corneal transplant called posterior lamellar keratoplasty. It aims to understand long-term outcomes for patients who had this surgery.
Hear when a new Pseudophakic Bullous Keratopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.